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b-lactam antibiotics aremost frequently used as empiric therapy
against Streptococcus pyogenes (b-hemolytic streptococcus) and
Staphylococcus aureus, which are the most common pathogens of
cellulitis.1 Clavulanic acid (CLAV) is a b-lactam antibiotic with a
weak antibacterial potential but a strong b-lactamase inhibitory ac-
tivity, and is employed as a combination form with amoxicillin
(AMOX). Here, we report a patient with cellulitis, who was treated
with the combination of AMOX and CLAV, and developed a drug
eruption to CLAV with characteristic sparing of cellulitis-affecting
site.
A 46-year-old Japanese woman presented with acute onset of
tender erythema on the dorsum of the left foot. Under the diagnosis
of cellulitis, she was treated with oral AMOX/CLAV. The next day,
the tender erythema extended to the left lower extremity
(Fig. 1a), representing lymphangitis. She also developed erythema-
tous macules and papules mainly on the right aspect of herFig. 1. Clinical ﬁndings (a, b) and histopathological ﬁndings (c, d). (a) Cellulitis and lymphan
thigh. (c) Histopathology of the lesion on the left lower limb, showing edema and degenerat
the lesion on the abdomen, showing inﬁltration of lymphocytes and eosinophils in the upp
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licenses/by-nc-nd/4.0/).abdomen and the right inguinal region, extending to the right thigh
(Fig. 1b). A biopsy specimen from her left shin showed a diffuse
inﬁltrate of neutrophils and lymphocytes in the dermis and fat tis-
sue with edema and fat degeneration (Fig. 1c), conﬁrming cellulitis
or phlegmone. Meanwhile, a biopsy specimen from her right
abdomen exhibited perivascular inﬁltrates of lymphocytes and eo-
sinophils in the upper dermis with invasion of lymphocytes into the
epidermis (Fig. 1d), suggesting a drug eruption. AMOX/CLAV, as the
culprit drug, was discontinued, and intravenous cefazolin therapy
was administered. The treatment improved both cellulitis and
drug eruption.
She regularly received valproic acid for cerebral palsy and ferric
pyrophosphate for iron-deﬁciency anemia. These drugs were not
discontinued during her clinical course. To determine the causative
drug, we performed skin patch tests, which showed a positive reac-
tion to AMOX/CLAV at 48 h, but not AMOX alone, valproic acid, or
ferric pyrophosphate. Results of skin prick tests were all negative.
We also performed the oral challenge test with AMOX, whichgitis on the left lower extremity. (b) Drug eruption on the right abdomen and the right
ion in the deep dermis and fat, suggestive of cellulitis (HE, 200). (d) Histopathology of
er dermis, compatible with drug eruption (HE, 200).
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a T-cell-mediated drug eruption to CLAV.
Although initial studies showed that CLAV had a low immuno-
genic capacity, CLAV may be the component responsible for hyper-
sensitivity reactions in AMOX/CLAV.2 There are few reports of
hypersensitivity to CLAV,3 presumably because AMOX/CLAV is a
material available for skin tests in clinical practice. In our case,
the drug eruption occurred during AMOX/CLAV therapy. She devel-
oped a maculopapular-type eruption due to CLAV. We observed the
drug eruption on the next day to AMOX/CLAV administration. The
onset of our case was immediate in consideration of ordinary
delayed hypersensitivity reaction. As far as we checked the pa-
tient's medical history, she had not received AMOX/CLAV therapy.
However, she might have been sensitized with CLAV in the past.
Alternatively, it is possible that she was sensitized with another
drug possessing cross-reactivity with CLAV.
It was speculated that delayed hypersensitivity reactions were
prone to take place in association with cellulitis.4 In our case, how-
ever, the drug eruption was markedly observed on the right
abdomen and right lower limb, sparing the left aspects where the
cellulitis occurred. The mechanism underlying this phenomenon
remains unclear, but the cellulitis-associated stimulation of Th1
cells might depress the drug eruption-exerting Th2 cells and eosin-
ophils in the left abdomen and lower limb. Given Th1 and Th17 cells
are activated in cellulitis, these T cell populations might induce the
drug eruption.5 It is also possible that T cells inducing the drug
eruption may be deleted in the cellulitis side.Conﬂict of interest
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